|
1
|
American Cancer Society: Cancer Facts
& Figures 2015. American Cancer Society, Inc.; Atlanta, GA:
2015
|
|
2
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lindgren D, Liedberg F, Andersson A,
Chebil G, Gudjonsson S, Borg A, Månsson W, Fioretos T and Höglund
M: Molecular characterization of early-stage bladder carcinomas by
expression profiles, FGFR3 mutation status, and loss of 9q.
Oncogene. 25:2685–2696. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Habuchi T, Marberger M, Droller MJ,
Hemstreet GP III, Grossman HB, Schalken JA, Schmitz-Dräger BJ,
Murphy WM, Bono AV, Goebell P, et al: Prognostic markers for
bladder cancer: International Consensus Panel on bladder tumor
markers. Urology. 66(Suppl 1): S64–S74. 2005. View Article : Google Scholar
|
|
5
|
Kamai T, Takagi K, Asami H, Ito Y, Oshima
H and Yoshida KI: Decreasing of p27Kip1 and cyclin E
protein levels is associated with progression from superficial into
invasive bladder cancer. Br J Cancer. 84:1242–1251. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liukkonen T, Rajala P, Raitanen M, Rintala
E, Kaasinen E and Lipponen P; The Finnbladder Group: Prognostic
value of MIB-1 score, p53, EGFr, mitotic index and papillary status
in primary superficial (Stage pTa/T1) bladder cancer: A prospective
comparative study. Eur Urol. 36:393–400. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Z, Liu K, Wang Y, Xu Z, Meng J and Gu
S: Upregulation of microRNA-96 and its oncogenic functions by
targeting CDKN1A in bladder cancer. Cancer Cell Int. 15:1072015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lei M, Xie W, Sun E, Sun Y, Tian D, Liu C,
Han R, Li N, Liu M, Han R, et al: microRNA-21 regulates cell
proliferation and migration and cross talk with PTEN and p53 in
bladder cancer. DNA Cell Biol. 34:626–632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiu Y, Liu Z, Xia S, Jin C, Yin H, Zhao W
and Wu Q: MicroRNA-137 upregulation increases bladder cancer cell
proliferation and invasion by targeting PAQR3. PLoS One.
9:e1097342014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Y, Kang Y, He Y, Liu J, Liang B, Yang
P and Yu Z: microRNA-99a acts as a tumor suppressor and is
down-regulated in bladder cancer. BMC Urol. 14:502014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu D, Zhou Y, Pan H, Zhou J, Fan Y and Qu
P: microRNA-99a inhibiting cell proliferation, migration and
invasion by targeting fibroblast growth factor receptor 3 in
bladder cancer. Oncol Lett. 7:1219–1224. 2014.PubMed/NCBI
|
|
13
|
Zhang J, Wang S, Han F, Li J, Yu L, Zhou
P, Chen Z, Xue S, Dai C and Li Q: MicroRNA-542-3p suppresses
cellular proliferation of bladder cancer cells through
post-transcriptionally regulating survivin. Gene. 579:146–152.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park SL, Cho TM, Won SY, Song JH, Noh DH,
Kim WJ and Moon SK: MicroRNA-20b inhibits the proliferation,
migration and invasion of bladder cancer EJ cells via the targeting
of cell cycle regulation and Sp-1-mediated MMP-2 expression. Oncol
Rep. 34:1605–1612. 2015.PubMed/NCBI
|
|
15
|
Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS,
Song PH, Choi YH, Kim IY, Moon SK and Kim WJ: Cell-free microRNAs
in urine as diagnostic and prognostic biomarkers of bladder cancer.
Int J Oncol. 41:1871–1878. 2012.PubMed/NCBI
|
|
16
|
Moon SK, Jung SY, Choi YH, Lee YC,
Patterson C and Kim CH: PDTC, metal chelating compound, induces G1
phase cell cycle arrest in vascular smooth muscle cells through
inducing p21Cip1 expression: Involvement of p38 mitogen
activated protein kinase. J Cell Physiol. 198:310–323. 2004.
View Article : Google Scholar
|
|
17
|
Lee SJ, Cho SC, Lee EJ, Kim S, Lee SB, Lim
JH, Choi YH, Kim WJ and Moon SK: Interleukin-20 promotes migration
of bladder cancer cells through extracellular signal-regulated
kinase (ERK)-mediated MMP-9 protein expression leading to nuclear
factor (NF-κB) activation by inducing the up-regulation of
p21WAF1 protein expression. J Biol Chem. 288:5539–5552.
2013. View Article : Google Scholar
|
|
18
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase
progression. Genes Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reis ST, Leite KR, Piovesan LF,
Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP,
Srougi M, et al: Increased expression of MMP-9 and IL-8 are
correlated with poor prognosis of Bladder Cancer. BMC Urol.
12:182012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seiler R, Thalmann GN and Fleischmann A:
MMP-2 and MMP-9 in lymph-node-positive bladder cancer. J Clin
Pathol. 64:1078–1082. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lam LT, Lu X, Zhang H, Lesniewski R,
Rosenberg S and Semizarov D: A microRNA screen to identify
modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).
Mol Cancer Ther. 9:2943–2950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eissa S, Ahmed MI, Said H, Zaghlool A and
El-Ahmady O: Cell cycle regulators in bladder cancer: Relationship
to schistosomiasis. IUBMB Life. 56:557–564. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shan G and Tang T: Expression of cyclin D1
and cyclin E in urothelial bladder carcinoma detected in tissue
chips using a quantum dot immunofluorescence technique. Oncol Lett.
10:1271–1276. 2015.PubMed/NCBI
|
|
26
|
Zhao X, Li J, Huang S, Wan X, Luo H and Wu
D: MiRNA-29c regulates cell growth and invasion by targeting CDK6
in bladder cancer. Am J Transl Res. 7:1382–1389. 2015.PubMed/NCBI
|
|
27
|
FitzGerald MG, Harkin DP, Silva-Arrieta S,
MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein
DM, Isselbacher KJ, et al: Prevalence of germ-line mutations in
p16, p19ARF, and CDK4 in familial melanoma: Analysis of a
clinic-based population. Proc Natl Acad Sci USA. 93:8541–8545.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lopez-Beltran A, Luque RJ,
Alvarez-Kindelan J, Quintero A, Merlo F, Carrasco JC, Requena MJ
and Montironi R: Prognostic factors in stage T1 grade 3 bladder
cancer survival: The role of G1-S modulators (p53, p21Waf1,
p27kip1, Cyclin D1, and Cyclin D3) and proliferation index
(ki67-MIB1). Eur Urol. 45:606–612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zang WQ, Yang X, Wang T, Wang YY, Du YW,
Chen XN, Li M and Zhao GQ: MiR-451 inhibits proliferation of
esophageal carcinoma cell line EC9706 by targeting CDKN2D and
MAP3K1. World J Gastroenterol. 21:5867–5876. 2015.PubMed/NCBI
|
|
30
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramón de Fata F, Ferruelo A, Andrés G,
Gimbernat H, Sánchez-Chapado M and Angulo JC: The role of matrix
metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of
metalloproteinases as serum markers of bladder cancer. Actas Urol
Esp. 37:480–488. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mian BM, Dinney CP, Bermejo CE, Sweeney P,
Tellez C, Yang XD, Gudas JM, McConkey DJ and Bar-Eli M: Fully human
anti-interleukin 8 antibody inhibits tumor growth in orthotopic
bladder cancer xenografts via down-regulation of matrix
metal-loproteases and nuclear factor-kappaB. Clin Cancer Res.
9:3167–3175. 2003.PubMed/NCBI
|
|
33
|
Lee EJ, Lee SJ, Kim S, Cho SC, Choi YH,
Kim WJ and Moon SK: Interleukin-5 enhances the migration and
invasion of bladder cancer cells via ERK1/2-mediated
MMP-9/NF-κB/AP-1 pathway: Involvement of the p21WAF1 expression.
Cell Signal. 25:2025–2038. 2013. View Article : Google Scholar : PubMed/NCBI
|
